Navigation Links
GlaxoSmithKline 14th Annual IMPACT Awards Seek Greater Philadelphia and Camden Healthcare Nonprofits

PHILADELPHIA, Feb. 15 /PRNewswire-FirstCall/ -- The GlaxoSmithKline (NYSE: GSK) 14th Annual IMPACT Awards target community-based nonprofits that provide access to healthcare for the underserved. Up to ten organizations in the Pennsylvania counties of Berks, Bucks, Chester, Delaware, Lancaster, Lehigh, Montgomery, and Philadelphia and the City of Camden, New Jersey, will be awarded $40,000 each. The awards are bestowed upon winning organizations for success and achievements in their current, overall work, not just for new or specific initiatives. Applications will be accepted through March 29, 2010, 4:00 p.m. EDT.

Every year the GlaxoSmithKline IMPACT Awards acknowledge, highlight and reward nonprofit organizations that have a significant impact on their communities and are accomplished, proactive and effective in their work. GlaxoSmithKline's IMPACT Awards represent and support Innovation, Management, Partnership, Achievement, Community focus and Targeting needs within community-based healthcare organizations. Nonprofits that exemplify the IMPACT Awards criteria continue to provide quality, accessible healthcare to their communities despite their financial and resource limitations. Winners in previous years include organizations that provide medical and dental care for the underserved, access to care for the chronically ill, services for children with genetic disorders and comprehensive treatment for women with addiction.

To qualify for a GlaxoSmithKline IMPACT award, applicants must provide access to healthcare services (primary mission); have annual total operating expenses between $160,000 and $3 million, as documented in the organization's most recent fiscal year financial statement; and have been in existence as a 501(c)(3) nonprofit organization for at least five years. A panel of local and national healthcare delivery experts and GlaxoSmithKline representatives will determine the winners based on a strong demonstration of ongoing success in providing access to healthcare; commitment to serving people in need; facilitation of healthcare delivery, substantive partnerships; policy development; and a solid record of achievement, management and leadership.

The GlaxoSmithKline IMPACT Awards will be presented at an awards ceremony in Philadelphia in late 2010. For more details and to apply, please visit the GlaxoSmithKline site at and select "Our work with communities," then click "Health programs," then click "Awards," and finally click "Philadelphia region" or call GlaxoSmithKline Community Partnerships at 215-751-5171.

About GlaxoSmithKline: GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information, visit GlaxoSmithKline on the World Wide Web at

SOURCE GlaxoSmithKline



SOURCE GlaxoSmithKline
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
2. GlaxoSmithKline Accelerates Review of Exelixis XL880
3. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
4. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
5. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
6. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
7. GlaxoSmithKline Reports Further Progress of Oncology Portfolio
8. GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)
9. GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
10. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
11. Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study
Post Your Comments:
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology:
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from reveals that behind the tendency to set low expectations ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
Breaking Medicine News(10 mins):